TECH·August 2, 2026[Review of Innovative Pharmaceutical Companies] ⑫ ABL Bio, led by LO, faces the challenge of completing clinical trials블로터
TECH·August 2, 2026Fursys bets on subscription service...financial structure remains solid despite turning to a loss블로터
TECH·August 2, 2026The era of hardship is over: LG Display targets 1 trillion won in operating profit as its earnings rebound gains traction블로터
TECH·August 2, 2026[Apartment PF Inside] Siheung The Class, maturity of subordinated 40 billion won debt extended again블로터
TECH·August 2, 2026Shanghai in China to subsidize purchases of wearable robots, boosting the Physical AI market블로터
TECH·August 2, 2026Stock market recovery remains sluggish despite rate freeze… the trap of long-term interest rates블로터
TECH·August 2, 2026Samsung Fire & Marine Insurance differentiates the treatment journey... Why it held a cancer treatment seminar블로터
TECH·August 2, 2026[Funding Preview] Meritz Financial and Hana F&I public bonds... Fantagio starts follow-on offering블로터
